Woodline Partners LP

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1784547 San Francisco, CA

Position in XENE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$8,740,061

+$7,382,267 QoQ

Shares Held

150,302

+246.5% QoQ

Ownership

0.155%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,424,016,489 across 189 Biotechnology names. XENE ranks #92 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	QNCX	Quince Therapeutics, Inc.	5,200,000	$105,040,000
5	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
6	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
7	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
8	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,740,061	150,302	+246.5%	Shares	Sole	2026-05-15
2025-06-30	$1,357,794	43,380	+8.6%	Shares	Sole	2025-08-14
2024-12-31	$1,565,569	39,938	-79.7%	Shares	Sole	2025-02-14
2023-12-31	$9,048,625	196,453	+36.9%	Shares	Sole	2024-02-14
2023-09-30	$4,900,286	143,451	-50.6%	Shares	Sole	2023-11-14
2023-06-30	$11,180,400	290,400	-30.9%	Shares	Sole	2023-08-14
2023-03-31	$15,032,837	420,029	+40.7%	Shares	Sole	2023-05-15
2022-12-31	$11,767,489	298,440	-26.2%	Shares	Sole	2023-02-14
2022-09-30	$14,597,359	404,359	+76.6%	Shares	Sole	2022-11-14
2022-06-30	$6,963,989	228,928	+14.5%	Shares	Sole	2022-08-15
2021-09-30	$3,055,755	199,984	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.